首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名：Gastroenterology and hepatology

缩写：

ISSN：1554-7914

e-ISSN：

IF/分区：0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引2416条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Seladelpar Is Associated With a Sustained Reduction in Cholestatic Markers and a Consistent Safety Profile in Patients With PBC Treated Up to 48 Months in the Ongoing, Open-Label ASSURE Study [0.03%] 开放标签ASSURE研究：塞拉德帕尔与PBC患者长达48个月的治疗相关的胆汁淤积标志物持续降低及一致的安全性特征
Gastroenterology & hepatology. 2025 Dec;21(12 Suppl 10):2-3. DOI: 2025
36 Months of Treatment With Seladelpar Is Associated With Stable or Improved Liver Stiffness in Patients With PBC [0.03%] seladelpar治疗PBC患者36个月与稳定的或改善的肝硬度相关
Gastroenterology & hepatology. 2025 Dec;21(12 Suppl 10):7-8. DOI: 2025
Sustained and Clinically Meaningful Improvements in Moderate to Severe Pruritus Patients With PBC Treated With Seladelpar: Results From the ASSURE Study Up to 30 Months [0.03%] 一项ASSURE研究长达30个月的结果：Seladelpar治疗PBC患者中至重度瘙痒持续且临床上有意义的改善
Gastroenterology & hepatology. 2025 Dec;21(12 Suppl 10):4-5. DOI: 2025
Long-term Treatment With Elafibranor Leads to Biochemical and Symptomatic Improvements for at Least 3 Years in Patients With PBC [0.03%] エルafilbranorの長期投与によりPBC患者さんが3年以上化学的・症候学的に改善する可能性が示唆されました
Gastroenterology & hepatology. 2025 Dec;21(12 Suppl 10):3-4. DOI: 2025
Volixibat Leads to Improvements in Fatigue and Sleep for Adults With PBC: Data From VANTAGE [0.03%] VANTAGE数据：Volixibat可改善PBC成人患者的疲劳和睡眠症状
Gastroenterology & hepatology. 2025 Dec;21(12 Suppl 10):8. DOI: 2025
Interventional Endoscopic Ultrasound: Next Frontier or Dead End? [0.03%] 介入性超声内镜：下一个前沿领域还是死胡同？
Marc Giovannini Marc Giovannini
Gastroenterology & hepatology. 2025 Dec;21(12):779-782. DOI: 2025
Insights Into Colonoscopic Surveillance for Dysplasia in Inflammatory Bowel Disease [0.03%] 炎症性肠病患者异型增生内镜筛查的现状及未来方向
James D Lewis James D Lewis
Gastroenterology & hepatology. 2025 Dec;21(12):765-767. DOI: 2025
The Evolving Field of Interventional Endoscopic Ultrasound [0.03%] 介入内镜超声的发展历程与现状展望
Gary R Lichtenstein Gary R Lichtenstein
Gastroenterology & hepatology. 2025 Dec;21(12):732. DOI: 2025
Evolution of Advanced Combination Treatment in Inflammatory Bowel Disease [0.03%] 炎症性肠病复杂治疗的演进
Arpita Jajoo,Katherine Margolin,Berkeley N Limketkai et al. Arpita Jajoo et al.
Despite multiple new advanced therapeutic options for the treatment of inflammatory bowel disease (IBD), almost half of patients do not achieve clinical remission and the number requiring intestinal resection has not significantly changed i...
Gastroenterology & hepatology. 2025 Dec;21(12):745-756. DOI: 2025
Highlights From the Recent AASLD AST Practice Guideline on Adult Liver Transplantation and Graft-Related Complications [0.03%] 美国肝病研究学会(AASLD)2023年成人肝脏移植及移植物相关并发症实践指南精华解读
Elizabeth Verna Elizabeth Verna
Gastroenterology & hepatology. 2025 Dec;21(12):773-775. DOI: 2025